Management of Apricus Bio Highlights Corporate Development, Drug Registration and Out-Licensing Progress at Two Biotech Conferences
January 12, 2011 13:51 ET
|
Seelos Therapeutics, Inc.
SAN FRANCISCO, Jan. 12, 2011 (GLOBE NEWSWIRE) -- Dr. Bassam Damaj, President and Chief Executive Officer of Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), today presented at the Fourth...
Apricus Biosciences and Elis Pharma Sign License Agreement for Vitaros(R) in the Gulf and Part of the Middle East
January 04, 2011 10:13 ET
|
Seelos Therapeutics, Inc.
SAN DIEGO and DUBAI, United Arab Emirates, Jan. 4, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) and Elis Pharmaceuticals ("Elis"), announced today that the two...
Apricus Biosciences and Bracco Sign Licensing Agreement for Vitaros(R) in Italy
December 22, 2010 14:05 ET
|
Seelos Therapeutics, Inc.
SAN DIEGO, Dec. 22, 2010 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that it has entered into a licensing agreement granting Bracco SpA ("Bracco") the...
Apricus Biosciences Announces Upcoming Presentations at the 4th Annual OneMedForum San Francisco and the Biotech Showcase 2011
December 13, 2010 09:57 ET
|
Seelos Therapeutics, Inc.
SAN DIEGO, Dec. 13, 2010 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that Dr. Bassam Damaj, President and Chief Executive Officer, will provide company...